Bruce Levine, PhD
University of Pennsylvania
Philadelphia, PA, United States

[1] A. Caplan, B. Levine, Hope, Hype and Help: Ethically Assessing the Growing Market in Stem Cell Therapies, Am. J. Bioeth. 10(5) (2010) 24-25.
[2] K.C. Gunter, A.L. Caplan, C. Mason, R. Salzman, W.E. Janssen, K. Nichols, L.F. Bouzas, F. Lanza, B.L. Levine, J.E.J. Rasko, A. Shimosaka, E. Horwitz, Cell therapy medical tourism: Time for action, Cytotherapy 12(8) (2010) 965-968.
[3] M. Dominici, K. Nichols, A. Srivastava, D.J. Weiss, P. Eldridge, N. Cuende, R.J. Deans, J.E.J. Rasko, A.D. Levine, L. Turner, D.L. Griffin, L. O’Donnell, M. Forte, C. Mason, E. Wagena, W. Janssen, R. Nordon, D. Wall, H.N. Ho, M.A. Ruiz, S. Wilton, E.M. Horwitz, K.C. Gunter, Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective, Cytotherapy 17(12) (2015) 1663-1666.
[4] M. Khoury, L. Ikonomou, M. Dominici, K. LeBlanc, B.L. Levine, D.J. Weiss, The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?, Stem Cells Dev. 30(3) (2021) 119-127.
[5] N. Cuende, R. Ciccocioppo, M. Forte, J. Galipeau, L. Ikonomou, B.L. Levine, A. Srivastava, P.J. Zettler, Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products, Cytotherapy (2022).
[6] B.L. Levine, M. Munsie, A.D. Levine, L. Ikonomou, C. International Society for, C. Gene Therapy Committee on the Ethics of, T. Gene, The peril of the promise of speculative cell banking: Statement from the ISCT Committee on the Ethics of Cell and Gene Therapy, Cytotherapy (2022).